CorVel Corporation (CRVL)
NASDAQHealth CareInsurance - BrokersSnapshot 2026-09-04
$68.23-0.66%
Close 2026-09-04 · 1-day change
NASDAQHealth CareInsurance - BrokersSnapshot 2026-09-04
QuarterlyIQ Insights · CRVL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2012 | Mar 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 983.7 | 958.5 | 895.6 | 795.3 | 718.6 | 646.2 | 552.6 | 592.2 | 595.7 | — | — | — | — | — | — | — |
| Total Revenues | 983.7 | 958.5 | 895.6 | — | 718.6 | — | — | — | — | — | — | — | — | — | — | — |
| Cost of Revenues | 739.8 | 725.7 | 685.9 | 623.6 | 560.3 | 494.1 | 429.0 | 466.3 | 470.9 | 451.1 | 413.9 | 399.0 | 392.7 | 370.3 | 337.7 | 318.8 |
| Gross Profit | 243.9 | 232.9 | 209.7 | 171.7 | 158.3 | 152.1 | 123.6 | 125.9 | 124.8 | 107.3 | 104.8 | 104.5 | 100.0 | 108.5 | 91.7 | 93.8 |
| Operating Expenses & Income | ||||||||||||||||
| Operating Income | 151.2 | — | — | — | 84.6 | 84.5 | 59.2 | 60.7 | 61.5 | 47.9 | 47.5 | 46.1 | 45.6 | 56.5 | 43.9 | 43.4 |
| Earnings from Continuing Operations | ||||||||||||||||
| EBT, Incl. Unusual Items | 151.2 | 143.1 | 120.8 | 95.1 | 84.6 | 84.5 | 59.2 | 60.7 | 61.5 | 47.9 | 47.5 | 46.1 | 45.6 | 56.5 | 43.9 | 43.4 |
| Income Tax Expense | 35.9 | 32.8 | 25.7 | 18.8 | 18.2 | 18.1 | 12.8 | 13.3 | 14.8 | 12.2 | 18.1 | 17.5 | 17.0 | 22.1 | 17.2 | 16.9 |
| Net Income | ||||||||||||||||
| Net Income | 115.3 | 110.3 | 95.2 | 76.3 | 66.4 | 66.4 | 46.4 | 47.4 | 46.7 | 35.7 | 29.5 | 28.5 | 28.6 | 34.4 | 26.7 | 26.6 |
| Per Share | ||||||||||||||||
| Basic EPS | 2.27 | 2.15 | 1.85 | 4.45 | 1.28 | 3.74 | 2.59 | 2.59 | 2.48 | 1.90 | 1.52 | 1.44 | 1.38 | 1.63 | 1.20 | 1.16 |
| Diluted EPS | 2.26 | 2.14 | 1.83 | 4.40 | 1.26 | 3.66 | 2.55 | 2.55 | 2.46 | 1.87 | 1.51 | 1.43 | 1.37 | 1.61 | 1.19 | 1.14 |
| Revenue per Share | 19.32 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 50.8 | 51.3 | 51.4 | 17.1 | 52.0 | 17.8 | 17.9 | 18.3 | 18.8 | 18.8 | 19.4 | 19.8 | 20.7 | 21.1 | 22.3 | 23.0 |
| Diluted Weighted Avg Shares | 50.9 | 51.6 | 52.0 | 17.3 | 52.8 | 18.1 | 18.2 | 18.6 | 19.0 | 19.0 | 19.6 | 20.0 | 20.9 | 21.4 | 22.5 | 23.3 |
| Supplemental | ||||||||||||||||
| EBITDA | — | — | — | — | 109.7 | 108.4 | 82.6 | 83.2 | 84.5 | 69.7 | 68.5 | 66.0 | 63.6 | 72.9 | 59.6 | 58.2 |
| EBIT | 151.2 | — | — | — | 84.6 | 84.5 | 59.2 | 60.7 | 61.5 | 47.9 | 47.5 | 46.1 | 45.6 | 56.5 | 43.9 | 43.4 |
| Effective Tax Rate | 23.7% | — | — | — | 21.5% | 21.4% | 21.7% | 22.0% | 24.1% | 25.5% | 38.0% | 38.1% | 37.3% | 39.1% | 39.1% | 38.9% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.